ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      58,180.70
      -0.21%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Centogene NV (CNTG)

      7. Centogene NV (CNTG) News

      CNTG

      Centogene NV (CNTG)

      Centogene NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CNTG
      DateTimeSourceHeadlineSymbolCompany
      12/01/20214:10AMTipRanksLeerink Partners Thinks Centogene NV’s Stock is Going to RecoverNASDAQ:CNTGCentogene NV
      11/25/20218:36AMTipRanksCentogene Uncertain on “Going Concern”; Shares Tank 19%NASDAQ:CNTGCentogene NV
      11/24/20217:42AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      11/24/20217:35AMGlobeNewswire Inc.CENTOGENE Reports Third Quarter 2021 Financial ResultsNASDAQ:CNTGCentogene NV
      11/18/20218:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      11/18/20216:30AMGlobeNewswire Inc.CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021NASDAQ:CNTGCentogene NV
      11/04/20216:30AMGlobeNewswire Inc.CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood DiseasesNASDAQ:CNTGCentogene NV
      10/28/20216:30AMGlobeNewswire Inc.CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical StudyNASDAQ:CNTGCentogene NV
      10/28/20216:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      10/06/20218:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      10/06/20218:00AMGlobeNewswire Inc.CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare DiseasesNASDAQ:CNTGCentogene NV
      09/29/20215:05PMGlobeNewswire Inc.CENTOGENE’s Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth DefectsNASDAQ:CNTGCentogene NV
      09/07/20216:35AMGlobeNewswire Inc.CENTOGENE Reports Second Quarter 2021 Financial ResultsNASDAQ:CNTGCentogene NV
      09/01/20216:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      09/01/20216:30AMGlobeNewswire Inc.CENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021NASDAQ:CNTGCentogene NV
      07/27/20216:37AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      07/27/20216:30AMGlobeNewswire Inc.CENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and DevelopmentNASDAQ:CNTGCentogene NV
      07/12/20216:22AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CNTGCentogene NV
      07/07/20216:07AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CNTGCentogene NV
      06/25/20216:30AMGlobeNewswire Inc.CENTOGENE Announces Shareholders Approve All Resolutions at Annual General MeetingNASDAQ:CNTGCentogene NV
      06/22/20216:30AMGlobeNewswire Inc.CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 YearsNASDAQ:CNTGCentogene NV
      06/16/20216:55AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      06/16/20216:30AMGlobeNewswire Inc.CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to Virtual Investor EventNASDAQ:CNTGCentogene NV
      06/09/20214:30PMGlobeNewswire Inc.CENTOGENE to Announce Q1 2021 Financial Results on June 16, 2021NASDAQ:CNTGCentogene NV
      06/08/20216:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      06/07/20216:30AMGlobeNewswire Inc.CENTOGENE Announces Virtual Investor EventNASDAQ:CNTGCentogene NV
      06/02/20216:31AMGlobeNewswire Inc.CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic Forms of Frontotemporal DementiaNASDAQ:CNTGCentogene NV
      06/02/20216:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      06/01/20216:30AMGlobeNewswire Inc.CENTOGENE Launches NEW CentoXome® - An Enhanced Whole Exome Sequencing SolutionNASDAQ:CNTGCentogene NV
      05/26/20216:30AMGlobeNewswire Inc.CENTOGENE Announces the Nomination of Rene Just as Chief Financial OfficerNASDAQ:CNTGCentogene NV
       Showing the most relevant articles for your search:NASDAQ:CNTG